Picture a finance director in Midtown who has done everything right on paper. She books her annual physical every spring, her blood pressure comes back fine, and the printout puts her BMI in the green band. (She is a composite, here to make the questions concrete.) Then a colleague mentions a concierge practice on the Upper East Side. The pitch is easy to follow: more time with the doctor and a wider menu of tests. She starts wondering what the extra would actually change.
Fair question. A longer appointment catches only what somebody thinks to look for, so the useful way to read an executive physical is item by item. For each add-on, what does the standard number leave out, and what does the extra measurement show? What follows walks through those items for one reader in particular, someone of South Asian descent in New York or anywhere else, whose risk may sit where the default charts don't look.
What a longer visit has room for
Time is the main product. A tight clinic schedule leaves space for a weight, a blood pressure reading and a glance at last year's results. A longer visit leaves space for a tape measure, a proper family history, and a conversation about why a number moved since the last time.
That space only helps if the doctor knows what each result stands in for. Each figure on a lab sheet is a stand-in for something else. BMI stands in for body fat. HbA1c stands in for blood sugar. A good physical, then, is one where the doctor can name the stand-in and say where it breaks.
There is a second reason time matters. A result with no context is easy to misread in either direction. A number that sits inside the printed range can still describe a body that is carrying risk, and a number outside it can come from the test itself. You want a doctor who has enough of the hour left to tell the two apart, and who will say so when the answer is that the test has to be repeated another way.
Why a normal BMI can hide a lot
A 2025 review of the Asian Indian phenotype describes a profile that pairs a BMI in the normal range with heavy body and belly fat and little muscle, with limited fat stored under the skin and more of it stored in the liver and pancreas. That pattern is why visceral fat can stay high at a normal BMI: the fat sits around the organs that handle sugar and fat, out of sight of both the scale and the chart. It is also the reason metabolic risk can appear at a lower BMI than a standard chart would warn about.
Back to the finance director. If she has this profile, the green band tells her little about her liver and pancreas. A waist measurement tells her more, and a direct body-fat reading tells her more again. Neither would be a diagnosis. Both would change the next question. A BMI that looked reassuring in the waiting room starts to look incomplete, and the doctor has a reason to look at the blood work with more care.
The tape measure and the body-fat reading
In January 2025 a commission convened by The Lancet Diabetes & Endocrinology, with Rubino and colleagues reporting, published a framework for diagnosing clinical obesity. It treats BMI as a gauge of risk across populations. One person's diagnosis needs more. To confirm excess body fat in one person, the framework asks for a direct body-fat measurement where one is available, or at least one body measurement taken alongside BMI: waist circumference, waist-to-hip ratio or waist-to-height ratio, judged against cutoffs that suit the person's age, sex and ethnicity. Clinical obesity then requires reduced organ function or limits on daily activity on top of the excess fat. The framework also names a stage before that, preclinical obesity, where there is excess fat but organs and tissues still work normally, and the risk of moving on to clinical obesity varies from person to person.
That split changes what a physical is for. A visit that stops at a BMI can only say heavier or lighter. A visit that measures fat and then looks at function can say where you are on the road, which is a more useful thing to hear at a routine check than a colour band on a printout.
Treat it as a good set of questions from an expert commission and nothing more official than that. None of the measurements needs an expensive machine. A waist measurement needs a tape and a clinician who thinks to use it. That is exactly the kind of habit a longer appointment makes room for.
India's expert consensus from 2025 draws a similar line. Its first stage covers extra body fat that has not yet touched organ function or everyday activity. Its second stage adds a large waist or waist-to-height ratio and requires a sign that function is limited or that a related illness has appeared, type 2 diabetes and knee osteoarthritis being the examples given. A 2025 review describes the first stage as managed mainly with lifestyle change and the second as warranting more intensive interventions. Those decisions belong to the patient and the treating doctor, which is the point of having a long appointment at all.
Blood sugar numbers and the blood behind them
HbA1c comes from the red blood cells, which means a change in those cells moves the reading. The NGSP keeps a list of what interferes with it, and some entries deserve a place in the conversation.
Low iron with anaemia goes along with a higher HbA1c, and once the iron is treated the number drops. The opposite direction exists too. Red cells that die early, as in haemolytic anaemia or after a sudden blood loss, pull the result down falsely, whichever assay the lab runs. The variant haemoglobins HbS, HbC, HbE and HbD can shift accuracy, and by how much depends on the method. HbE trait shows it well: no significant interference when the lab detects it, an artificially low result when it goes undetected.
So the plain question is worth asking out loud. Could anything about my blood make this number unreliable, and would a different test settle it? If the finance director has a variant haemoglobin or a thalassaemia trait, her HbA1c may not be reliable, and her doctor may reach for other tests. It is the sort of detail a hurried visit has no slot for.
Two more situations are worth a sentence each. In people on dialysis HbA1c may read lower than their true sugar, and its place in kidney disease is a matter of debate. In late pregnancy it climbs in women without diabetes, driven by iron deficiency. A physician who asks about both before reading the number is doing what you are paying the longer visit to get.
A table to carry into the appointment
Four items anchor the conversation, and each has a blind spot worth naming. The table pairs each with the question that exposes it.
| The number | What it can miss | A question to ask |
|---|---|---|
| BMI | Fat sitting around the waist, liver and pancreas | Is a waist measurement or a direct body-fat reading beside it? |
| Waist circumference | Whether the cutoff was set for South Asian bodies | Which cutoff are you applying to me? |
| HbA1c | Anaemia, blood loss, haemoglobin variants | Which method did the lab use, and does another glucose test make sense? |
| Excess body fat alone | Whether organs or daily activity are affected | What are you checking for effects on organ function? |
Which cutoffs, and why the answer matters
Ask which cutoffs the doctor is applying. A consensus published in 2009 in the Journal of the Association of Physicians of India set lower BMI and waist cutoffs for Indians than the general-population ones. The 2025 revision of the Indian definition keeps a lower BMI threshold for adiposity and puts abdominal fat at the centre of its second stage. India's large ICMR-INDIAB prevalence studies classify general and abdominal obesity with the WHO Asia-Pacific criteria.
In New York the wrinkle is practical. A chart on the wall may be built for a general population, and a South Asian patient who reads "normal" off it deserves a second look at the waist. Any result that looks off belongs in a conversation with your own doctor, not in a search bar. Take the questions from the table, ask them in the room, and write the answers down. Bring last year's lab sheet too, and ask the doctor to point at the line where each question applies. If you take a high-dose biotin supplement, mention that too. The FDA has warned that biotin can push some immunoassay results falsely up or down, thyroid tests among them, and wants patients to mention biotin and multivitamins to their clinician and the lab.
What I can't tell you about any one practice
Menus differ between practices, and a longer menu is not a better physical. Whether a given New York practice measures a waist, orders a body-fat reading or tells you which HbA1c method its lab uses is something only a call to the front desk will settle. I can't say the fee is worth it. I can say what to do with the time once you have it, and that the finance director's green band deserved a few more questions than it got.